European Union - English - EMA (European Medicines Agency)

mcm vaccine b.v. - diphtheria toxoid, tetanus toxoid, bordetella pertussis antigens: pertussis toxoid, filamentous haemagglutinin, pertactin, fimbriae types 2 and 3, hepatitis b surface antigen produced in yeast cells, poliovirus (inactivated): type 1 (mahoney), type 2 (mef-1), type 3 (saukett) produced in vero cells/ haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate) conjugated to meningococcal protein. - meningitis, haemophilus; poliomyelitis; tetanus; diphtheria; whooping cough; hepatitis b - vaccines - vaxelis (dtap-hb-ipv-hib) is indicated for primary and booster vaccination in infants and toddlers from the age of 6 weeks, against diphtheria, tetanus, pertussis, hepatitis b, poliomyelitis and invasive diseases caused by haemophilus influenzae type b (hib). the use of vaxelis should be in accordance with official recommendations.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

sanofi-aventis (malaysia) sdn. bhd. - inactivated poliomyelitis virus,type 3; inactivated poliomyelitis virus,type 2; inactivated poliomyelitis virus,type 1 -

Malta - English - Medicines Authority

glaxosmithkline biologicals s.a. rue de l'institut 89 b-1330 rixensart, belgium - pertactin, pertussis filamentous, haemagglutinin, pertussis toxoid, poliovirus, inactivated, type, mahoney strain, mef, saukett strain, diphtheria toxoid, haemophilus influenzae, type b, polysaccharide, polyribosylribitol phosphate, tetanus toxoid - powder and suspension for suspension for injection - pertactin 8 µg pertussis filamentous haemagglutinin 25 µg pertussis toxoid 25 µg poliovirus (inactivated) type 1 (mahoney strain) 40 dagu/0.5ml poliovirus (inactivated) type 2 (mef-1 strain) 8 dagu/0.5ml poliovirus (inactivated) type 3 (saukett strain) 32 dagu/0.5ml diphtheria toxoid haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate) 10 µg tetanus toxoid - vaccines

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

sanofi-aventis (malaysia) sdn. bhd. - diphtheria toxoid; haemophilus influenza type b conjugate; tetanus toxoid; pertussis toxoid (pt); filamentous haemagglutinin (fha); inactivated poliomyelitis virus,type 3; inactivated poliomyelitis virus,type 2; inactivated poliomyelitis virus,type 1 -

Kenya - English - Pharmacy and Poisons Board

beijing institute of biological products co.,ltd no 6&9 bo'xing 2nd road economic-technological - type i, ii, iii inactivated purified monovalent… - injection - type 1_>700 du/ml, type 2_>500 du/ml, type…

Canada - English - Health Canada

sanofi pasteur limited - pertussis toxoid; filamentous haemagglutinin; fimbriae; pertactin; diphtheria toxoid; tetanus toxoid; inactivated poliomyelitis vaccine (d.c.o.) type 1 mahoney; inactivated poliomyelitis vaccine (d.c.o.) type 2 mef1; inactivated poliomyelitis vaccine (d.c.o.) type 3 saukett; haemophilus influenzae type b-prp; tetanus protein - liquid - 20mcg; 20mcg; 5mcg; 3mcg; 15lf; 5lf; 40unit; 8unit; 32unit; 10mcg; 30mcg - pertussis toxoid 20mcg; filamentous haemagglutinin 20mcg; fimbriae 5mcg; pertactin 3mcg; diphtheria toxoid 15lf; tetanus toxoid 5lf; inactivated poliomyelitis vaccine (d.c.o.) type 1 mahoney 40unit; inactivated poliomyelitis vaccine (d.c.o.) type 2 mef1 8unit; inactivated poliomyelitis vaccine (d.c.o.) type 3 saukett 32unit; haemophilus influenzae type b-prp 10mcg; tetanus protein 30mcg - vaccines

Canada - English - Health Canada

sanofi pasteur limited - tetanus toxoid; diphtheria toxoid; inactivated poliomyelitis vaccine (d.c.o.) type 3 saukett; inactivated poliomyelitis vaccine (d.c.o.) type 2 mef1; inactivated poliomyelitis vaccine (d.c.o.) type 1 mahoney - suspension - 5lf; 2lf; 32unit; 8unit; 40unit - tetanus toxoid 5lf; diphtheria toxoid 2lf; inactivated poliomyelitis vaccine (d.c.o.) type 3 saukett 32unit; inactivated poliomyelitis vaccine (d.c.o.) type 2 mef1 8unit; inactivated poliomyelitis vaccine (d.c.o.) type 1 mahoney 40unit - toxoids

Canada - English - Health Canada

sanofi pasteur limited - pertactin; pertussis toxoid; diphtheria toxoid; tetanus toxoid; inactivated poliomyelitis vaccine (v.c.o.) type 1 mahoney; inactivated poliomyelitis vaccine (v.c.o.) type 2 mef1; inactivated poliomyelitis vaccine (v.c.o.) type 3 saukett; haemophilus influenzae type b-prp; tetanus protein; filamentous haemagglutinin; fimbriae - suspension - 3mcg; 20mcg; 15lf; 5lf; 29unit; 7unit; 26unit; 10mcg; 30mcg; 20mcg; 5mcg - pertactin 3mcg; pertussis toxoid 20mcg; diphtheria toxoid 15lf; tetanus toxoid 5lf; inactivated poliomyelitis vaccine (v.c.o.) type 1 mahoney 29unit; inactivated poliomyelitis vaccine (v.c.o.) type 2 mef1 7unit; inactivated poliomyelitis vaccine (v.c.o.) type 3 saukett 26unit; haemophilus influenzae type b-prp 10mcg; tetanus protein 30mcg; filamentous haemagglutinin 20mcg; fimbriae 5mcg - vaccines

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - polio virus type 1 40 dagu; polio virus type 2 8 dagu; polio virus type 3 32 dagu - solution for injection - active: polio virus type 1 40 dagu polio virus type 2 8 dagu polio virus type 3 32 dagu excipient: albumin formaldehyde phenoxyethanol

Singapore - English - HSA (Health Sciences Authority)

sanofi-aventis singapore pte. ltd. - inactivated poliomyelitis virus type 1 (mahoney); inactivated poliomyelitis virus type 2 (mef-1); inactivated poliomyelitis virus type 3 (saukett) - injection - 8 d.u. - inactivated poliomyelitis virus type 1 (mahoney) 40 d.u./0.5 ml; inactivated poliomyelitis virus type 2 (mef-1) 8 d.u./0.5 ml; inactivated poliomyelitis virus type 3 (saukett) 32 d.u./0.5 ml